source
- American Cancer Society recommends routine PSA screening for men 50-69, strengthens guidance for high-risk groupsThe American Cancer Society (ACS) has updated its prostate-cancer screening guidelines, now advising men at average risk aged 50 to 69 to have a PSA blood test every two years. This replaces the 20…
- Kyverna pauses development of next-gen autoimmune CAR-T KYV-102 to focus on neurologic miv-cel programKyverna Therapeutics announced it is halting work on its next-generation CD19 CAR-T candidate KYV-102, which had been positioned as a follow-up to its lead autoimmune CAR-T miv-cel. KYV-102 was de…